Background--Germinal matrix hemorrhage (GMH) is a leading cause of mortality and lifelong morbidity in preterm infants. Posthemorrhagic hydrocephalus (PHH) is a common complication of GMH. A sodium-coupled bicarbonate exchanger (NCBE) encoded by solute carrier family 4 member 10 gene is expressed on the choroid plexus basolateral membrane and may play a role in cerebrospinal fluid production and the development of PHH. Following GMH, iron degraded from hemoglobin has been linked to PHH. Choroid plexus epithelial cells also contain iron-responsive element-binding proteins (IRPs), IRP1, and IRP2 that bind to mRNA ironresponsive elements. The present study aims to resolve the following issues: (1) whether the expression of NCBE is regulated by IRPs; (2) whether NCBE regulates the formation of GMH-induced hydrocephalus; and (3) whether inhibition of NCBE reduces PHH development.
G
erminal matrix hemorrhage (GMH) develops secondary to the rupture of fragile blood vessels within the subependymal brain tissue. It affects between 12.5% and 22% of infants with birth weights <1500 g. 1, 2 Immature blood vessels in the germinal matrix are deficient in autoregulatory mechanisms and may therefore rupture in response to abnormal fluctuations of cerebral blood flow, caused by cardiorespiratory instability, among others, in the perinatal period. 3 Long-term consequences of GMH include developmental delays, cerebral palsy, and posthemorrhagic hydrocephalus (PHH), which pose a relevant social and economic burden on those affected. 2, 4, 5 Approximately 25% of premature infants who have GMH will develop progressive PHH and 40% of those who survive the initial events will require surgery for permanent cerebrospinal fluid (CSF) diversion. 2 The need for CSF diversion, however, is an independent risk factor for poor neurological outcome following GMH. 6 Insufficient advancements targeting the development of PHH have been made. Noninvasive treatment strategies that effectively reduce PHH formation after GMH would greatly benefit this patient population. PHH is believed to be caused by an obstruction within the CSF circulation and/or by an imbalance between CSF formation and absorption. 7 Impaired CSF absorption may be explained by mechanical and inflammatory destruction of the arachnoid granulations; however, the mechanisms of increased CSF production after GMH are not well understood. A sodiumcoupled bicarbonate exchanger (NCBE) encoded by the solute carrier family 4 member 10 (slc4a10) gene is expressed on the basolateral side of choroid plexus epithelial cells, which is reputed to play a role in CSF production. 8 Indeed, mice with targeted disruption of the slc4a10 gene developed cerebroventricular systems of small volume, suggesting a pertinent role of this specific ion transporter in CSF. 9 The choroid plexus epithelial cells also contain iron-responsive element-binding protein (IRP) 1 and IRP2, which bind to sequences of mRNA known as iron-responsive elements, thereby regulating the translation of iron storage and transport proteins. An important consequence of intraventricular hemorrhage is the release of iron from hemoglobin molecules of lysed erythrocytes, which creates a neurotoxic oxidative environment. 10 High iron concentrations have been shown to reduce the binding affinity of IRP1 to iron-responsive elements and may even cause degradation of IRP2. 11 Synthesis of the iron storage protein, ferritin, and the iron transporter protein, transferrin, is greatly dependent on IRPs, and thus may be impaired following GMH. 12, 13 The present study aims to determine whether GMH-induced or iron trichloride (FeCl 3 )-induced iron overload decreases IRP1 and IRP2 expressions and increases NCBE expression for possible roles in CSF production and development of PHH. We hypothesize that iron overload decreases IRP1/IRP2 and increases NCBE expression, while increasing CSF production and PHH. Our results confirm our hypotheses and suggest a noncanonical relationship between decreased IRP1/IRP2 levels and increased NCBE levels. Our findings suggest that combined iron chelation and slc4a10 knockout may be effective in decreasing CSF production and hydrocephalus formation in patients with GMH.
Materials and Methods
The data, analytic methods, and study materials have been made available to other researchers for purposes of reproducing the results or replicating the procedure. The data that support the findings of this study are available from the corresponding author upon request. Authors will be responsible for maintaining availability.
GMH Modeling and Treatment
All procedures were in compliance with the National Institutes of Health guidelines for the handling of laboratory animals and approved by the Institutional Animal Care and Use Committee at Loma Linda University.
P7 Sprague-Dawley rat pups (stage of brain development is comparable to an infant at 30-32 weeks of gestation) were implemented in this study. We used stereotactic infusion of 0.3 U of bacterial collagenase into the right ganglionic eminence to induce grade III and IV GMH, as previously described.
14 Briefly, rat pups were anesthetized with 3%
isoflurane (in mixed air and oxygen) and placed prone onto a stereotactic head frame. Aseptic techniques were used for all animal surgeries. Following a small longitudinal midline scalp incision, the bregma was identified. A 1-mm burr hole was made 1.6 mm rostral and 1.5 mm right lateral relative to the bregma. A 27-gauge needle was inserted stereotactically through the burr hole 2.7 mm in depth and collagenase was infused. Following that, the needle was left in place for an additional 5 minutes to prevent backflow of collagenase along the needle tract. After removal of the syringe, the burr hole was sealed with bone wax and the incision was closed with sutures. Sham animals were subjected to the same procedure excluding infusion of collagenase. A subgroup of na€ ıve animals received intracerebral injections of FeCl 3 , instead of collagenase . Deferoxamine (100 mg/kg) or its vehicle (PBS) was injected intraperitoneally every 12 hours, starting 1 hour after GMH induction. slc4a10 small interfering RNA (siRNA) or scrambled siRNA was injected intracerebroventricularly at the following coordinates relative to the bregma: 1.6 mm (rostral), 1.5 mm (left lateral), and 1.7 mm (in depth). slc4a10 siRNA was administered 1 day before GMH induction and then every 7 days thereafter for 21 consecutive days (for the long-term experiments). slc4a10 siRNA (Applied Biological Materials Inc.) was packaged in lentivirus targeting multiple sequences, including 1598CCACCGAAGGTCGTATAAGTGCAATCGAA;1839 TTCCCTTGTCTGCTATATCACCCGGTTCA;2623GCAGCCACTGT CCTCTCCATCACTCATGT;3060 GTTGATGGACTTCTTGTTTACCA AACGGG.
Experiment 1
To determine the time course of IRP2 and NCBE expressions following GMH, animals subjected to GMH were euthanized on days 1, 3, 5, or 7 after surgery and brain tissues were collected for Western blotting and real-time polymerase chain
Clinical Perspective
What Is New?
• This is the first study that related iron overload with a sodium transporter on the choroid plexus epithelial cells.
What Are the Clinical Implications?
• It revealed a potential novel mechanism that leads to cerebrospinal fluid overproduction and hydrocephalus and highlighted the role of sodium-coupled bicarbonate exchanger in cerebrospinal fluid production, which can be a novel therapeutic target for posthemorrhagic hydrocephalus.
reaction (PCR). A sham group was included for comparison (n=6 for each group per time point).
Experiment 2
We tested the effects of iron toxicity on IRP1, IRP2, and NCBE expression levels at 3 days after GMH as well as the longterm effects of iron toxicity on neurological deficits at 21 to 28 days after GMH, the rate of CSF production, and the extent of PHH at 28 days after GMH. We administered deferoxamine to chelate iron after GMH/FeCl 3 . The following experimental groups were used: sham, GMH+vehicle, GMH+deferoxamine, FeCl 3 +vehicle, and FeCl 3 +deferoxamine. On day 3 after GMH, a subgroup of animals was euthanized for Western blotting, real-time PCR (n=6 for each group), and immunofluorescence staining (n=4 for sham, GMH+vehicle, GMH+deferoxamine group). All other animals (n=6 for sham, GMH+vehicle, GMH+deferoxamine group), as well as sham+deferoxamine, were included in the long-term experiments to evaluate neurological deficits at 21 to 28 days after GMH. Sham, GMH+vehicle, and GMH+deferoxamine animals were also used to measure the rate of CSF production, as well as the extent of PHH at 28 days after GMH.
Experiment 3
To determine whether knockdown of slc4a10 ameliorates CSF overproduction and hydrocephalus formation, thereby improving long-term neurological deficits after GMH, the following experimental groups were selected: sham, GMH, GMH+scrambled siRNA, and GMH+slc4a10 siRNA. On day 3 after GMH, a subgroup of animals was euthanized for Western blotting, real-time PCR (n=6 for each group), and immunofluorescence staining (n=4 for sham, GMH+scrambled siRNA, GMH+slc4a10 siRNA group). All other animals (n=6 for each group), as well as sham+slc4a10 siRNA, were included in the long-term experiments to evaluate neurological deficits at 21 to 28 days after GMH. Sham, GMH+scrambled siRNA, and GMH+slc4a10 siRNA groups were used to measure the rate of CSF production, as well as the extent of PHH at 28 days after GMH.
Preparation of Brain Tissue
At 3 and 28 days after GMH induction, deeply anesthetized (5% isoflurane) animals were subjected to transcardiac perfusion with ice-cold PBS for Western blotting, real-time PCR, or ice-cold PBS followed by 10% formalin for immunohistochemistry and other histological evaluation. Brains were snap-frozen in liquid nitrogen and stored at À80°C (for Western blotting and real-time PCR) or post-fixed in 10% formalin overnight then dehydrated with a sucrose solution (30%) for an additional 3 days at 4°C (for histology studies). Forebrain samples used for staining were then embedded in optimal cutting temperature compound and stored at À20°C.
Protein Extraction and Western Blotting
Forebrain samples were homogenized in RIPA lysis buffer (Santa Cruz Biotechnology) and supernatants from the homogenates were collected after centrifugation at 20817 g, at 4°C for 30 minutes. The protein concentration was determined using a detergent compatibility assay (Bio-Rad). Thirty micrograms of protein per sample were loaded, run for 30 minutes at 80 V, then 60 minutes at 120 V, followed by protein transfer onto nitrocellulose membranes at 0.45 mm for 120 minutes (Bio-Rad). Membranes were incubated for 2 hours in 5% nonfat milk in Tris-buffered saline containing 0.1% Tween 20. The following primary antibodies were incubated overnight at 4°C: anti-IRP1 and anti-IRP2 (1:1000; Abcam), anti-NCBE (1:500; Origene) and anti-b-Actin (1:1000; Santa Cruz Biotechnology). The membranes were washed and then incubated with the appropriate secondary antibodies (1:4000, Santa Cruz Biotechnology) for 1 hour at room temperature. Enhanced chemiluminescent solution (GE Healthcare and Life Science) was then applied to the membranes and the protein bands were exposed onto radiography films. ImageJ software (4.0, Media Cybernetics) was used to analyze the relative density of the resultant protein immunoblots.
RNA Extraction and Real-Time PCR
RNA was extracted from forebrain homogenates using the Quick-RNA MiniPrep kit (Genesee Scientific) according to the manufacturer's instructions. RNA concentrations were determined by photometric measurement via the NanoDrop 2000 spectrophotometer (Peqlab Biotechnologie GmbH). Firststrand cDNA Synthesis Kit (ThermoFisher) was used for reverse transcription. Three micrograms of RNA was reverse transcribed per the manufacturer's instructions. Quantitative real-time PCR was performed on a CFX96 Touch Real-Time PCR Detection System machine using iTaq Universal SYBR Green Supermix (Bio-Rad) according to the manufacturer's instructions. Primers used in the study were as follows: slc4a10 forward primer 5 0 -GCA AGG TGC TTT TTC CAG AGG- 
phase consists of 40 cycles of amplification using a plateau of 95°C for 30 seconds for denaturation, followed by a plateau of 60°C for 1 minute for annealing, and a plateau of 72°C for 30 seconds for amplification. All real-time PCRs were performed in triplicates. Results were quantitated using DDCt method.
Immunohistochemistry and Volumetric Analysis
Following postfixation of the brain samples in formalin, 10-lm thick coronal sections were cut using a cryostat (Leica Microsystems LM3050S). Brain sections revealing choroid plexus were used for immunohistochemical staining as previously described. 15 Briefly, these brain sections were incubated overnight at 4°C with the following primary antibodies: anti-IRP1 (1:200, Abcam), anti-IRP2 (1:100, Abcam), anti-NCBE (1:50, Origene), and antitransthyretin (1:50, Abcam). Sections were then washed and incubated with the appropriate secondary antibodies (1:100, Jackson ImmunoResearch Labs) for 2 hours at room temperature. The tissue slides were then stained with 4',6-diamidino-2-phenylindole (Vector Laboratories), fixed in paramount, and visualized using a fluorescence microscope (Olympus BX51, Olympus Corporation). For histological, volumetric analysis, 16-lm thick coronal brain sections were cut at 2.5 mm, 1.2 mm, 0.7 mm rostral, and 2.9 mm caudal of the bregma. These brain slices were stained with Nissl and morphometrically analyzed using ImageJ 4.0 (Media Cybernetics) assisted delineation of brain structures, as previously described. 16 The ventricle volume was calculated as average ventricular areas on each slide multiplied by the depth of the cerebroventricular system.
Neurobehavioral Assessment
Morris water maze and rotarod tests were performed in a blinded manner to evaluate cognitive and sensorimotor deficits in rats between 21 and 28 days after GMH induction, as previously described. 17, 18 Briefly, for the water maze test, rats were placed in a round pool (110 cm in diameter) filled with water and trained to find a visible platform (11 cm in diameter). After these cued trials, the platform was slightly submerged and the rats were allowed to find the location of the platform on 10 trials per day for 4 consecutive days. Additionally, at the end of each test day, the platform was removed from the pool (Probe trial). An overhead camera with a computerized tracking system (Noldus Ethovision) recorded the swim path and measured the swim distance and time spent within the probe quadrant. Briefly, for the rotarod test, rats were placed onto a rotarod (Columbus Instruments), consisting of a rotating horizontal cylinder (7 cm in diameter).
Rats had to move along with the rotating cylinder to avoid falling. Rotarod testing started at either 5 or 10 RPM with an acceleration of 2 RPM every 5 seconds. A photobeam circuit detected the fall off the cylinder and the latency to this event was recorded for each animal.
Measuring CSF Production
CSF production was measured by the ventriculo-cisternal perfusion method. 19 Briefly, after introduction of the micropipette in the contralateral lateral ventricle to the GMH site, a second micropipette held in a horizontal position was inserted into the cisterna magna micropipette. After observing CSF in the cisterna magna micropipette, the perfusion was started. The lateral ventricle was perfused with artificial CSF containing 10 mg/mL of fluorescein isothiocyanate dextran (500 000 MW, ThermoFisher) with a total volume of 100 and 80 lL fluid in the cisterna magna was collected. This procedure lasted for 40 minutes. Sham-operated animals also received the same infusion and withdrawal of fluid.
The rate of CSF production was calculated from the equation V f =r i (C i ÀC o )/C o . V f was the CSF production rate (lL/min), r i was the infusion rate (1 lL/min), C i was the dextran concentration of inflow solution (10 mg/mL), and C o was the dextran concentration of outflow solution. Absorbance of the fluid collected was measured at 498 nm.
Concentrations of the solution were calculated based on a standard curve.
Statistical Analysis
Statistical analysis was performed using Sigma Plot10.0 and Sigma Stat3.5 (Systat Software). Data were presented as meanAESEM and evaluated by 1-way ANOVA followed by Tukey or Student-Newman-Keuls tests. P values <0.05 were considered statistically significant.
Results

GMH Decreased IRP2 Expression and Increased NCBE Expression
A time-course study was conducted to determine IRP2 and NCBE protein expression and gene transcription in the forebrain of rats on 1, 3, 5, and 7 days following GMH induction. We found that IRP2 protein expression was significantly decreased in GMH animals starting from day 1 to day 5 compared with the sham group or GMH animals euthanized on day 7 after surgery (P<0.05; Figure 1A ). IRP2 protein expression was found to be similar on day 7 after GMH compared with the sham group (P>0.05). Reversely, the expression of the NCBE was found to be significantly elevated following GMH between day 1 and day 5 compared with the sham or GMH day 7 group (P<0.05; Figure 1B ) but was found to be similar to sham on day 7 after GMH (P>0.05). IRP2 and slc4a10 mRNA levels were also measured in the tissue samples collected on 1, 3, 5, and 7 days following GMH induction. The real-time PCR data revealed that IRP2 mRNA levels were significantly decreased while slc4a10 mRNA levels were significantly elevated on days 1, 3, and 5 after GMH compared with sham or the GMH day 7 group (P<0.05; Figure 1C and 1D). IRP2 expression as well as gene transcription was negatively associated with NCBE expression and slc4a10 gene transcription following GMH.
Iron Toxicity Increased Expression of NCBE After GMH/FeCl 3
The protein expression of NCBE as well as slc4a10 gene transcription was measured on day 3 after surgery in the following groups: sham, GMH+vehicle, FeCl 3 +vehicle, GMH+deferoxamine, and FeCl 3 +deferoxamine. Interestingly, GMH as well as FeCl 3 administration resulted in a significant increase in both protein and mRNA level of NCBE/slc4a10 (P<0.05; Figure 2A and 2B) compared with the sham group. The iron chelator deferoxamine significantly decreased the protein expression of NCBE after GMH (P<0.05 versus GMH+vehicle; Figure 2A ) as well as after FeCl 3 administration (P<0.05 compared with FeCl 3 +vehicle). Similarly, deferoxamine decreased the mRNA level of slc4a10 after GMH (P<0.05; Figure 2B ) and FeCl 3 administration (P<0.05) compared with the respective vehicle group. The expression of NCBE in the choroid plexus was evaluated via immunohistochemical staining of forebrain at 3 days after surgery. The following groups were compared: sham, GMH+vehicle, and GMH+de-feroxamine. As expected, NCBE localized basolateral membrane in choroid plexus cells ( Figure 2C ). Representative microphotographs demonstrated seemingly increased expression of NCBE after GMH administration (GMH+vehicle), which was reduced after deferoxamine treatment.
Deferoxamine Restored GMH/FeCl 3 Reduced IRP2 Expression
The protein and mRNA levels of IRP1 and IRP2 were measured on day 3 after surgery in the following groups: sham, Figure 3A and 3C). The protein expression of IRP2, however, was found to be significantly decreased in the GMH+vehicle and FeCl 3 +vehicle group compared with sham (P<0.05; Figure 3B ). The decrease in IRP2 expression after GMH and FeCl 3 administration was effectively reversed by deferoxamine compared with the respective vehicle groups (P<0.05). Similarly, the level of IRP2 mRNA was significantly decreased in the GMH+vehicle and FeCl 3 +vehicle group compared with sham (P<0.05; Figure 3D ). The decrease in IRP2 mRNA after GMH and FeCl 3 administration was also reversed by deferoxamine, compared with the respective vehicle groups (P<0.05). The expression of IRP2 within the choroid plexus was evaluated via immunohistochemical staining of forebrain slides obtained at 3 days after surgery.
The following groups were compared: sham, GMH+vehicle, and GMH+deferoxamine. Antitransthyretin antibody was used to identify the choroid plexus within the brain. IRP2 and antitransthyretin were colocalized within the same cells ( Figure 3E ). Representative microphotographs demonstrated seemingly decreased expressions of IRP2 after GMH (GMH+vehicle), which was ameliorated after deferoxamine treatment.
slc4a10 Gene Silencing Decreased NCBE Expression After GMH
The effectiveness of intracerebroventricular injection of slc4a10 siRNA was evaluated. One day before GMH surgery, slc4a10 siRNA or its control was injected into the left lateral ventricle of rat pups. Western blot and real-time PCR were conducted at 3 days after GMH induction to evaluate the effectiveness of slc4a10 knockdown. The protein expression of NCBE was significantly decreased after slc4a10 siRNA injection compared with the vehicle and vehicle+scrambled siRNA groups (P<0.05; Figure 4A ). Similarly, slc4a10 mRNA was significantly decreased after siRNA injection compared with the vehicle and vehicle+scramble siRNA groups (P<0.05; Figure 4B ). The expression of slc4a10 within the choroid plexus was evaluated via immunohistochemical staining of forebrain slides obtained at 3 days after surgery. The following groups were compared: sham, GMH+scrambled siRNA, and GMH+slc4a10 siRNA. NCBE localized basolateral membrane in choroid plexus cells ( Figure 4C ). Representative microphotographs demonstrated increased expression of NCBE after scramble siRNA injection; however, slc4a10 siRNA effectively reduced NCBE expression within the choroid plexus after GMH induction.
Deferoxamine and slc4a10 Knockdown Improved Neurological Function After GMH
Neurobehavioral deficits were evaluated between day 21 and 28 after GMH. The following groups were compared: sham, sham+deferoxamine, GMH+vehicle, GMH+deferoxamine, sham+slc4a10 siRNA, GMH+scrambled siRNA, and GMH+slc4a10 siRNA. During the Morris water maze trials, GMH+vehicle animals required significantly longer periods to find the platform compared with sham (P<0.05; Figure 5A , block 3). GMH+vehicle and GMH+scramble siRNA animals performed significantly worse than sham animals (P<0.05; Figure 5A , block 4). The greater amount of time required by vehicle animals to find the platform during water maze testing was significantly reduced by administration of slc4a10 siRNA in block 3 and by administration of deferoxamine or slc4a10 siRNA in block 4 compared with the respective vehicle groups (P<0.05). Furthermore, rodents of the GMH+vehicle and GMH+scrambled siRNA groups spent less time in the correct quadrant during the probe trials compared with either the sham group or animals of the respective vehicle groups (P<0.05; Figure 5B ), which indicated a significant loss of special memory in GMH animals. The latter was effectively ameliorated by deferoxamine treatment and slc4a10 gene silencing. Similarly, GMH animals (GMH+vehicle and GMH+scramble siRNA) fell faster off the rotating cylinder at a starting speed of 5 RPM compared with the sham, GMH+deferoxamine, and GMH+slc4a10 siRNA groups (P<0.05; Figure 5C ). GMH animals demonstrated a worse performance than sham animals during rotarod testing at a starting speed of 10 RPM (P<0.05); however, no significant improvement was found after deferoxamine treatment or slc4a10 knockdown (P>0.05). In general, deferoxamine and slc4a10 siRNA had no effect on sham-operated animals.
Deferoxamine and slc4a10 Gene Silencing Reduced CSF Production After GMH CSF production was evaluated in sham, GMH+vehicle, GMH+deferoxamine, GMH+scramble siRNA, and GMH+slc4a10 siRNA animals at 28 days after surgery. CSF production rate was found to be significantly increased in untreated GMH animals (GMH+vehicle and GMH+scrambled siRNA) compared with sham animals (P<0.05; Figure 6 ). Deferoxamine treatment and slc4a10 gene silencing resulted in significantly reduced CSF production rates compared with the respective vehicle group (P<0.05).
Deferoxamine and slc4a10 Knockdown Ameliorated PHH After GMH
The extent of PHH was evaluated in sham, GMH+vehicle, GMH+deferoxamine, GMH+scrambled siRNA, and GMH+slc4a10 siRNA animals at 28 days after surgery. Representative microphotographs of Nissl-stained coronal brain sections were obtained ( Figure 7A ). Volumetric analysis of coronal brain slides demonstrated significantly increased volumes of the cerebroventricular system of untreated GMH animals (GMH+vehicle and GMH+scrambled siRNA) compared with either sham or GMH+deferoxamine and GMH+slc4a10 siRNA animals (P<0.05; Figure 7B ). GMH+vehicle and GMH+scrambled siRNA animals were also found to have decreased cortical thicknesses compared with the sham group (P<0.05; Figure 7C ). Deferoxamine treatment and slc4a10 gene silencing tended to ameliorate the loss of cortical thickness after GMH; however, no significant difference was achieved (P>0.05). Furthermore, GMH+vehicle and GMH+scrambled siRNA animals demonstrated significant white matter losses compared with the sham group (P<0.05; Figure 7D ). Deferoxamine treatment and slc4a10 gene silencing tended to ameliorate the white matter loss after GMH; however, no significant difference was achieved (P>0.05).
Discussion
The formation of PHH is a well-described and common complication following GMH. 2 Currently, there is no effective treatment for PHH other than surgical shunting. In fact, the need for CSF diversion via ventriculoperitoneal or ventriculopleural shunt placement is an independent risk factor for an adverse neurological outcome following GMH. 6 While PHH is believed to be caused by an obstruction within the CSF circulation and/or by an imbalance between CSF formation and absorption, 7 insufficient advancements have been made targeting or preventing its formation. Intracerebroventricular accumulation of iron, resulting from degraded hemoglobin, has been linked to the development of PHH. 10 Using a preclinical rat pup model of GMH, which has been shown to induce PHH, 14, 18 we attempted to investigate whether GMHinduced iron overload decreases IRP1 and IRP2 expressions, and increases NCBE overexpression, resulting in increased CSF production and consequent PHH formation. We further attempted to evaluate whether iron chelation via deferoxamine or slc4a10 knockdown decreases the rate of CSF production, thereby decreasing hydrocephalus formation and improving neurobehavioral outcomes after GMH. Our data showed that mRNA and protein levels of slc4a10/NCBE significantly increased on days 1, 3, and 5 after GMH. Furthermore, IRP2 mRNA and protein levels were inversely related to slc4a10/NCBE. Interestingly, IRP1 expression was preserved after GMH. We further demonstrated increased NCBE expression localized on the choroid plexus basolateral membrane, the main source of CSF production. Since NCBE protein is significantly involved in CSF production, under pathophysiological circumstances, overexpression of the transporter could result in increased CSF production, thereby promoting PHH formation following GMH. Indeed, the CSF production rate significantly increased after GMH. Furthermore, iron chelation via deferoxamine and slc4a10 knockdown reduced the CSF production rate, which was associated with decreased ventricular dilation and improved neurobehavioral outcomes. These findings suggest that NCBE upregulation seems to be linked to iron toxicity, since improvements were observed after deferoxamine treatment, and possibly associated with IRP2. However, GMH did not significantly alter the expression of IRP1. The mechanism still needs to be further identified. The choroid plexus is an epithelial layer in the ventricles specialized for CSF production. 20, 21 It has relatively high expression of iron transport and iron-dependent metabolic proteins relative to other brain regions. 22 IRP1 and IRP2 are sensitive to cellular iron content and mediate changes in iron metabolism by binding to iron response elements on target mRNAs to alter their translation. Specifically, in the setting of iron overloading, IRP1 undergoes conformational changes, whereas IRP2 undergoes proteasomal degradation, both of which decrease IRP activity. 11 While IRP1 is more abundant in most cell types, IRP2 is strongly expressed in brain. 23 In red blood cells, at least, lack of IRP2 is not fully compensated by IRP1. 24 Following GMH, red blood cells enter the cerebroventricular system and release heme iron, which may adversely alter choroid plexus function. CSF secretion at the choroid plexus involves several ion transporters on both the basolateral and luminal membranes in which ions are pumped into the cerebroventricular system while water follows the osmotic gradient. 25 NCBE expressed on the choroid plexus plays an important role in CSF production. slc4a10 knockout seems to be more deleterious than the knockouts of other transporters implemented in CSF secretion. 25, 26 Indeed, mice with targeted slc4a10 gene disruption have smaller cerebrovascular systems compared with wild types. 9 There are multiple ion transporters expressed within the epithelial cells of the choroid plexus, such as sodium bicarbonate cotransporter 1, sodium-proton exchanger protein, and aquaporin 1, contributing to CSF secretion. However, NCBE might play a prominent role in CSF production since it is the only major transporter on the basolateral side of the epithelial cells. [25] [26] [27] While genes of similar ion transporters, such as slc11a2 and slc40a1, are regulated by IRPs through iron responsive elements, 28, 29 no such association between IRPs and NCBE is known.
Study Limitations
One of the limitations of this study is that we mainly focused on how iron overload is associated with NCBE, a major transporter located on the basolateral side. However, aquaporin 1 and Na+-K+-ATPase, located on the luminal side of the epithelial cells, also play a role in CSF production. Whether GMH causes any functional changes on the luminal side or whether there are any compensatory mechanisms with NCBE knockdown warrants further investigation.
Conclusions
In the present study, we demonstrated that GMH-induced iron overload decreases IRP2 expression, which was associated with an overexpression of NCBE. The latter was, at least in part, likely responsible for an increase in CSF production and consequent PHH formation. We believe that targeting the cereventricular iron and choroid plexus NCBE is a potential treatment strategy to decrease CSF production and hydrocephalus formation may improve neurological outcomes after GMH.
